Celecoxib drug study in children on leukemia treatment
Treatments studied
Part of Bones, joints & muscles, Pain clinical trials.
This trial studies how celecoxib moves through a child’s body and how much reaches the fluid around the brain and spinal cord. It’s for children (age 2–12) who are in the maintenance phase of certain blood cancers, to better understand dosing and safety.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Be age 2 to 12 years
- Be in the maintenance phase of treatment for ALL or lymphoblastic lymphoma, and in remission
- Not have certain blood cancer types like AML
- Have normal kidney and liver blood tests in the last 30 days
- No history of ulcer disease in the stomach or intestines
- No allergy to celecoxib or other anti-inflammatory pain medicines (NSAIDs)
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a combination of two immunotherapy drugs (durvalumab and tremelimumab) plus a pain reliever (celecoxib) for people with advanced liver cancer that cannot be removed by surgery. The goal is to see if this three-drug combination works better than standard treatments.
This trial tests whether adding celecoxib (an anti-inflammatory drug) to the standard R-CHOP chemotherapy regimen can improve outcomes for people with a specific, hard-to-treat type of diffuse large B-cell lymphoma (DLBCL) that is CD5-positive. It's for people who are newly diagnosed and have advanced disease.
This study tests whether adding celecoxib (an anti-inflammatory drug) to standard immunotherapy and chemotherapy improves outcomes for people with a specific type of bile duct cancer that has high levels of a protein called CK5/6. It aims to see if the combination is safe and effective.
This Phase 1/2 trial tests a combination of medicines (dasatinib, venetoclax, dexamethasone, cyclophosphamide, and cytarabine) in children and teens whose blood cancer has come back or did not respond to treatment. It aims to see whether this approach can control the cancer while checking what doses are safe.
This research study tests whether adding a drug called celecoxib (an anti-inflammatory pill) can help treat early-stage triple-negative breast cancer after surgery, before or during radiation therapy. You may be eligible if your cancer was removed cleanly and you do not have other health issues like stomach ulcers, kidney problems, or a history of allergic reactions to certain pain relievers.
This trial is testing if the medication celecoxib can stop or slow the growth of polyps in people with Peutz-Jeghers Syndrome (PJS). It may help reduce the need for surgery and lower the risk of complications.
Hear when a new Pharmacokinetics of Celecoxib in Children trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.